GlassScriptPhysician profile
Steven A Socher
NPI 1811993736
$1,453.91
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $498 · 2020: $152 · 2021: $188 · 2022: $280 · 2023: $298 · 2024: $39.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $277.69 | 2019-2023 | Myrbetriq |
| Abbvie INC. | $215.96 | 2019-2023 | Botox, Lupron Depot |
| Janssen Biotech, INC. | $177.41 | 2019 | |
| Allergan, INC. | $138.77 | 2019-2022 | |
| Travere Therapeutics, INC. | $81.98 | 2019-2021 | |
| Boston Scientific Corporation | $70.77 | 2020-2023 | Spaceoar Vue System - 10ml |
| Urovant Sciences INC | $59.61 | 2022 | |
| Sumitomo Pharma America, INC. | $45.05 | 2023 | Gemtesa |
| Endo Pharmaceuticals INC. | $45.02 | 2020-2023 | Aveed, Xiaflex |
| Tolmar, INC. | $44.36 | 2023 | |
| Myovant Sciences INC. | $43.48 | 2021 | |
| Procept Biorobotics Corporation | $42.49 | 2019-2023 | Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $34.68 | 2020-2022 | |
| C. R. Bard, INC. & Subsidiaries | $27.06 | 2020 | |
| Silk Road Medical, INC. | $25.48 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $18.50 | 2023 | Desara |
| Ferring Pharmaceuticals INC. | $17.38 | 2019 | |
| Coloplast Corp | $16.27 | 2022 | |
| Laborie Medical Technologies Corp. | $15.71 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $14.29 | 2021 | |
| Acerus Pharmaceuticals Corporation | $14.27 | 2020 | |
| Olympus America INC. | $13.94 | 2024 | Itind System |
| Axonics, INC. | $13.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Socher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.